High levels of PTH were already expected, and one objective of this study was to maintain the stability of PTH since there is evidence that the development of SRHP occurs in the early stages of CKD and reaches up to 100% in stage 4 [3,5]. This evidence concerns the gene PTH and chronic kidney disease.